[go: up one dir, main page]

WO2014093868A1 - Prétraitement par cryolipolyse et dispositif, système, kit et procédé d'ajustement de recherche - Google Patents

Prétraitement par cryolipolyse et dispositif, système, kit et procédé d'ajustement de recherche Download PDF

Info

Publication number
WO2014093868A1
WO2014093868A1 PCT/US2013/075091 US2013075091W WO2014093868A1 WO 2014093868 A1 WO2014093868 A1 WO 2014093868A1 US 2013075091 W US2013075091 W US 2013075091W WO 2014093868 A1 WO2014093868 A1 WO 2014093868A1
Authority
WO
WIPO (PCT)
Prior art keywords
applicators
applicator
cryolipolyis
cutaneous layer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2013/075091
Other languages
English (en)
Inventor
Andrew KORNSTEIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2014093868A1 publication Critical patent/WO2014093868A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001—Body part
    • A61F2007/0052—Body part for treatment of skin or hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0087—Hand-held applicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
    • A61F2007/0096—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0225—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof
    • A61F2007/0239—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof using vacuum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
    • A61F2007/029—Fat cell removal or destruction by non-ablative heat treatment

Definitions

  • Excess body fat, or adipose tissue can detract from personal appearance and athletic performance, and can pose significant health risks by increasing the likelihood of developing various types of diseases, for example, heart disease, high blood pressure, osteoarthritis, cancer, bronchitis, hypertension, diabetes, deep-vein thrombosis, pulmonary emboli, varicose veins, gallstones, and hernias.
  • diseases for example, heart disease, high blood pressure, osteoarthritis, cancer, bronchitis, hypertension, diabetes, deep-vein thrombosis, pulmonary emboli, varicose veins, gallstones, and hernias.
  • Surgical procedures such as liposuction have been employed to remove excess body fat. Due to its invasive nature, recovery time, potential complications and the cost of such surgical procedures, the demand for a safe, effective and incremental non-invasive alternative for body contouring have grown with the public's demand. Many non-invasive body contouring procedures exist in an attempt to remove or reduce adipose cells. These include topical agents, massages, acupuncture, weight-loss drugs, exercise, dieting, and applying heat to subcutaneous lipid-rich areas. However, each of the methods has limitations making the methods ineffective or impractical in certain circumstances.
  • cryolipolyis device The apparatus that is used to remove heat from the subcutaneous lipid-rich cells is often referred to as a cryolipolyis device.
  • Cryolipolyis devices may employ different types of applicators that are placed against the patient's epidermis to cool various target areas of the patient.
  • One type of applicator is a vacuum applicator, which includes a vacuum cup that has a pair of cutouts in which thermal conductors are positioned. A heat removal source is coupled to the exterior surface of the thermal conductors.
  • the vacuum applicator is placed against the cutaneous layer of the patient and the suction source is activated to draw the cutaneous layer into the interior cavity of the vacuum cup.
  • the vacuum applicator in order to be therapeutically successful, the vacuum applicator must fit a wide variety of body shapes and body contours and, in addition, the skin and fat roll must be "soft enough" to gain successful access between the cooling plates, with proper fit and fat roll compliance , the heat removal source is then activated to remove heat from the lipid-rich cells.
  • an applicator fit testing device assures the treating clinician and patient that proper fit with respect to body topography is possible and that the skin-subcutaneous region in question is of appropriate distensability and compliance to provide for adequate contact with the cooling device.
  • a series of applicators are tested to determine the best fit applicator. Once proper fit is assured, the best fit applicator is selected and treatment is commenced.
  • the fit testing device allows for easy clinical study to optimize development of an array of applicator shapes, sizes, dimensions and configurations. This optimizes clinical applicability, thereby, enabling the proposed biological fat melting mechanism to function optimally on the widest array of body types and regions.
  • a kit for fitting an applicator that is subsequently to be used during a cryolipolyis procedure.
  • the kit includes a plurality of applicators and a vacuum pump.
  • Each of the plurality of applicators engages with the cutaneous layer under which are lipid-rich cells to be treated by cryolipolyis.
  • Each of the applicators is different in size and/or shape.
  • the vacuum pump is removably couplable to each of the applicators for establishing a vacuum within an interior cavity of the applicators to thereby draw the cutaneous layer into the interior cavity when the applicators are in contact with the cutaneous layer.
  • a method for fitting an applicator to be used during a cryolipolyis procedure.
  • a first of a plurality of applicators are coupled to a vacuum pump.
  • Each of the plurality of applicators is configured to engage with the cutaneous layer under which are lipid-rich cells to be treated by cryolipolyis.
  • Each of the plurality of applicators is different in size and/or shape.
  • the first applicator is placed on the cutaneous layer. Suction is applied to the first applicator to draw the cutaneous layer into an interior cavity of the first applicator without cooling the cutaneous layer.
  • the aforementioned steps may be repeated for at least a second of the plurality of applicators.
  • One of the first or second applicators is selected for use during the cryolipolyis procedure based at least in part on the quality of the air-tight seal formed between the first and second applicators and the cutaneous layer.
  • FIG. 1 is a simplified, schematic diagram of a cryolipolyis device having a treatment device with a curved applicator.
  • FIG. 2 is a front perspective view of the curved applicator shown in FIG. 1.
  • FIG. 3 is a perspective view illustrating various aspects of the treatment device shown in FIG. 1
  • FIG. 4 is a perspective view of the vacuum cup employed in the curved applicator of FIG. 2.
  • FIG. 5 shows the treatment device of FIG. 1 when applied to a patient's hip.
  • FIG. 6 is a schematic cross-sectional view of a cooling unit that may be employed by the treatment device of FIG. 1.
  • FIG. 7 is a side view of an alternative embodiment of the treatment device.
  • FIG. 8 is a perspective view of another alternative embodiment of the treatment device.
  • FIG. 9 is a simplified, schematic diagram of an applicator fitting arrangement which may be used to select an appropriate applicator for use during a cryolipolyis treatment process.
  • cryolipolyis device described herein is suitable for treating a subject's
  • subcutaneous adipose tissue such as by cooling.
  • the "subcutaneous tissue” can include tissue lying beneath the dermis and includes subcutaneous fat, or adipose tissue that may be composed primarily of lipid-rich cells, or adipocytes.
  • subcutaneous lipid-rich cells can be affected selectively.
  • the epidermis and dermis of the subject lack lipid-rich cells compared to the underlying lipid-rich cells forming the adipose tissue.
  • the cryolipolyis device can apply cooling temperatures to the epidermis of the subject in a range of from about -20C to about 20C.
  • the cryolipolyis device can damage, injure, disrupt or otherwise reduce subcutaneous lipid-rich cells generally without collateral damage to non-lipid-rich cells in the treatment target area.
  • lipid-rich cells can be affected selectively (e.g., damaged, injured, or disrupted) by exposing such cells to low temperatures that do not so affect non-lipid-rich cells to the same extent or in the same manner.
  • lipid-rich cells such as subcutaneous adipose tissue, can be damaged while other cells in the same region are generally not damaged even though the non-lipid-rich cells at the surface are subject to even lower temperatures.
  • the mechanical energy provided by the applicator as well as manual pressure massage may further enhance the effect on lipid-rich cells by
  • FIG. 1 is a simplified, schematic diagram of a cryolipolyis device 100 having a treatment device 125 operatively coupled to a coolant vessel 140 to cool human tissue 110.
  • the device 100 is configured to cool subcutaneous, lipid-rich tissue 112, without damaging the overlying dermis 111.
  • the treatment device 125 is coupled to the coolant vessel 140 by a heat transfer conduit 150 that carries a heat transfer fluid.
  • the heat transfer conduit 150 includes a supply portion 151a that directs the heat transfer fluid to the treatment device 125, and a return portion 151b that receives heat transfer fluid exiting the treatment device 125.
  • the heat transfer fluid is propelled through the heat transfer conduit 150 by a fluid driver 170, e.g., a pump or other suitable device.
  • the heat transfer conduit 150 is typically insulated to prevent the ambient environment from heating the heat transfer fluid.
  • Other elements of the device (aside from the cooling surface of the applicator of the treatment device 125 in contact with the tissue 110) are also insulated from the ambient environment to prevent heat loss and frost formation.
  • suitable heat transfer fluid include, without limitation, water, glycol, synthetic heat transfer fluid, oil and a refrigerant.
  • the heat transfer conduit 150 is connected to a heat exchanger 160 having a heat exchanger conduit (e.g., tubing) 161 that is positioned within or at least partially within the coolant vessel 140.
  • the coolant vessel 140 contains a coolant 141 that is in close thermal contact with the heat exchanger 160, but is isolated from direct fluid contact with the heat transfer fluid contained within the heat exchanger tubing 161. Accordingly, the heat exchanger 160 facilitates heat transfer between the heat transfer fluid and the coolant 141, while preventing these fluids from mixing.
  • the coolant 141 can be selected to have a composition different than that of the heat transfer fluid.
  • cooling devices capable of removing heat may be employed, such as a refrigeration unit, a cooling tower, a
  • thermoelectric chiller or cooler may be incorporated into, or otherwise operatively associated with, a treatment unit that includes additional components such as a processor, an input device, an output device, a control panel and power supply.
  • the processor may monitor process parameters via sensors placed proximate to the treatment device 125 through a signal line to, among other things, adjust the heat removal rate based on process parameters.
  • the processor may further monitor process parameters to adjust the treatment device 125 based on the process parameters.
  • the input device may be, for example, a keyboard, a mouse, a touch screen, a push button, a switch, a potentiometer, any combination thereof, and any other device or devices suitable for accepting user input.
  • the output device may include, for example, a display or touch screen, a printer, a medium reader, an audio device, a visual device, any combination thereof, and any other device or devices suitable for providing user feedback.
  • the treatment device 125 is shown to include an applicator 128 and an applicator support 130.
  • the applicator 128 is coupled to the applicator support 130 at its proximal end. Details concerning aspects of the treatment device are shown in FIGs. 2-4.
  • like elements are denoted by like reference numerals.
  • FIG. 2 shows the applicator 128 itself, which includes a flexible vacuum cup 210 and cooling units 220a and 220b.
  • the vacuum cup 210 includes an interior surface 212 and an exterior surface 214.
  • the interior surface 212 defines an interior cavity 216 (see FIG. 3) in which a vacuum may be drawn.
  • the flexible vacuum cup 210 has a distal end defining the mouth of the interior cavity 216, which has a concave contoured distal surface 218 joining the interior and exterior surfaces 212 and 214.
  • the distal surface 218 contacts the epidermis of the patient when the treatment device 125 is applied thereto.
  • the vacuum that is applied by the treatment device 125 may be used to assist in forming a contact between the treatment device and the patient's epidermis.
  • the vacuum may also be used to impart mechanical energy during treatment. Imparting mechanical vibratory energy to a target area by, e.g., repeatedly applying and releasing a vacuum to the subject's tissue, or for instance, modulating a vacuum level applied to the subject's tissue to create a massage action during treatment.
  • control panel may be located on the applicator support 130 so as to be readily accessible to the operator of the cryolipolyis device.
  • the control panel may provide the operator with the ability to control and/or monitor treatment.
  • a first ON/OFF button may toggle the initiation or termination of a treatment and a second ON/OFF button may actuate a pump (not shown) for drawing a vacuum in the interior cavity 216.
  • Indicator lights may provide a visual indication of, for example, whether a treatment is proceeding and/or whether the vacuum pump is activated.
  • the applicator 128 and applicator support 130 may be operatively coupled to one another by a mounting plate 255 located at the proximal end of the interior cavity 216.
  • the mounting plate 255 may be integrally formed with the vacuum cup 210 or separately coupled to the vacuum cup 210.
  • An aperture 250 (see FIG. 4) in the mounting plate 255 provides a passage for drawing a vacuum in the interior cavity 216.
  • One or more fasteners may releasably secure the mounting plate 255 to the housing applicator support 130.
  • adhesive or another type of fastener may be used to couple the applicator 128 to the applicator support 130 either with or without using the mounting plate 225.
  • Additional apertures may be located in the mounting plate 255 to allow heat transfer conduit 150 and sensor wires to pass through the applicator support 130 and be coupled to the cooling units 220a and 220b.
  • the cooling units 220a and 220b are located in opposing sidewalls of the flexible vacuum cup 210. As shown in FIG. 4, the vacuum cup 210 may include cutouts located in opposing sidewalls each being defined by a support frame 230a and 230b.
  • the cooling units 220a and 220b are configured for heat transfer with respect to the lipid-rich cells when the contoured surface of the vacuum cup 210 contacts the cutaneous layer, which is drawn into the interior cavity 216 upon application of a vacuum within the vacuum cup 210. More particularly, the cooling units 220a and 22b each have a thermal conductor exposed to the interior cavity 216. One of the thermal conductors, thermal conductor 222b, is visible in FIG. 2. While cooling units 220a and 220b may employ any suitable technology in order to facilitate heat transfer, one example of a cooling unit 220a and 220b will be illustrated below which employs thermoelectric elements and a fluidic cryoprotectant.
  • the support frames 230a and 230b include rigid metal polygons, e.g., rectangles or squares with an intervening hinge of flexible material around which the flexible vacuum cup 210 may be molded. Accordingly, the support frames 230a and 230b may include a number of apertures, grooves, or other recesses into which the material of the flexible vacuum cup 210 may flow during a molding process to provide a strong connection between the support frames 230a and 230b and the vacuum cup 210.
  • the support frames 230a and 230b can be adhered, welded or otherwise coupled to the flexible vacuum cup 210 in the cutouts.
  • the cooling units 220a and 220b can each be secured to its respective support frame 230a and 230b by any suitable means, such as fasteners (e.g., screws), adhesive, welding or the like.
  • the cooling units 220a and 220b have an outer housing with distal surfaces 240a and 240b (see FIG. 2), respectively, which also have a concave contour.
  • distal surfaces 240a and 240b also contact the epidermis of the patient when the treatment device is applied thereto. That is, surfaces 218, 240a and 240b, which are all concave in shape, all face in a common direction so that they can contact the epidermis when applied to the patient.
  • the concavity of the distal surfaces 240a and 240b may be the same as the concavity of the distal surface 218.
  • the segments of the support frames 230a and 230b which are respectively secured to the surfaces 240a and 240b have the same concave curvature as the surfaces 240a and 240b.
  • the surfaces 240a and 240b may be offset in the proximal direction from the surface 218 by a distance, for example, of about one-half to three-quarters of an inch.
  • cooling units are shown to have a concave curvature on the distal end of their housings, in some embodiments the internal components of the cooling units may have the same curvature.
  • the thermal conductor 222b that contacts the patient's epidermis when drawn into the cavity by the vacuum cup may have a concave curvature.
  • FIG. 5 shows the treatment device 125 when applied to a patient's hip 400.
  • the distal surface 218 of the vacuum cup 210 and the distal surfaces 240a and 240b of the cooling units make good contact with the curved portion of the hip 400 to which the applicator 128 is applied.
  • an applicator in which these surfaces of the cooling units are linear is better suited to flat, two-dimensional regions on the patient's body, such as the abdomen, flanks and bras strap rolls.
  • FIG. 6 is a schematic cross-sectional view of a cooling unit 300 that may be used for one or both of the cooling units 220a and 220b in applicator 128.
  • the cooling unit includes a cooler 310 and an interface assembly 320 operably coupled to the cooler.
  • the cooler 310 includes a plate 312 that has a high thermal conductivity, one or more Thermoelectric Elements (TEEs) 314 and a coolant chamber 316.
  • TEEs Thermoelectric Elements
  • a coolant can recirculate through the coolant chamber 316 via inlet and outlet lines 151b and 151a, respectively, and the TEEs 314 can selectively heat and/or cool relative to the temperature of the coolant in the coolant chamber 316 to control the temperature over relatively large areas of the cooling plate 312.
  • Other embodiments of the cooling unit 310 do not include the TEEs 314 such that the coolant chamber 316 extends to the cold plate 312. In either case the cooling unit 310 provides a heat sink that cools the interface assembly 320.
  • the interface assembly 320 further controls the heat flux through a plurality of smaller zones and delivers a cryoprotectant to the target area.
  • the interface assembly 320 includes a cryoprotectant container 330 having a cavity 332 that contains a cryoprotectant 340 and an interface element 350 through which the cryoprotectant 340 can flow.
  • the cryoprotectant container 330 can be a rigid or flexible vessel having a back panel 334 facing the cooling unit 310 and a sidewall 336 projecting from the back panel 334.
  • the interface element 350 can be attached to the sidewall 336 to enclose the cavity 332.
  • the interface element 350 can include a contact member 352 having a backside 353a in contact with the cryoprotectant 340 and a front side 353b configured to contact the epidermis of the patient.
  • the contact member 352 can be a flexible barrier (e.g., membrane) such as a porous sheet of a polymeric material or a foil with small holes, a mesh, fabric or other suitable material through which the cryoprotectant 340 can flow from the backside 353a to the front side 353b.
  • the contact member 352 can be a substantially rigid barrier that is thermally conductive and configured to allow the cryoprotectant 340 to pass from the front side 353a to the backside 353b.
  • a rigid, thermally conductive contact member for example, can be a plate with holes or a panel made from a porous metal material. Suitable materials for a rigid contact member 352 include aluminum, titanium, stainless steel, or other thermally conductive materials.
  • the interface element 350 further includes an array of heating elements 354 carried by the contact member 352.
  • the individual heating elements 354 can be arranged in a grid or other type of pattern, and each heating element 354 is independently controlled relative to the other heating elements to provide control of the heat flux through smaller, discrete zones at the interface between the target area and the interface element 350.
  • the heating elements 354, for example, can be micro-heaters electrically coupled to a power source via a cable 355 such that the controller can selectably address individual heating elements 354.
  • the interface element 350 can further include a plurality of temperature sensors 356 carried by the contact member 352.
  • the temperature sensors 356 may be arranged in an array such that one or more temperature sensors can measure the heat flux through the heat flux zones associated with one or more individual heating elements 354.
  • the temperature sensors 356 can be electrically coupled to a control unit via a cable (not shown) in a manner similar to the heating elements 354.
  • the various elements of the cooling units 220a and 220b are configured to resist deformation such as bowing while a vacuum is drawn into the interior cavity 216 of the vacuum cup 210 so that the front side 353b of the interface element 350 can remain in thermal contact with the epidermis of the patient.
  • some or all of these elements of the cooling units may have an edge with a concave curvature that matches the concave curvature of the contact surfaces of the cooling unit housings in which they are located.
  • the contact member 352 which contacts the epidermis of the patient may have an edge with a concave curvature. This edge is indicated by reference numeral 245 in FIG. 2.
  • the interior cavity 216 of the vacuum cup 210 may be provided with a single cooling surface or a plurality of cooling surfaces disposed at discrete locations anywhere around the interior cavity, or the interior cavity may be partially or entirely provided with cooling surface(s).
  • the dimensions of the interior cavity 216 which would directly influence the size and shape of the contoured distal surface 218, the length of the vacuum cup 210 between its most remote ends (remote ends 402 and 404 in fig. 7) and the distance or gap between cooling units 220a and 220b on opposing sides of the vacuum cup.
  • the applicator can accommodate larger circumferential surfaces where adipose tissue resides.
  • the gap between cooling units the applicator can accommodate wider rolls of adipose tissue, therefore making the technology available to more potential patients.
  • the vacuum cup 210 may be provided with one or more expansion joints to better accommodate different arcs of curved surfaces as well as larger or smaller cutaneous and adipose body rolls.
  • One example of a treatment device having such an expandable applicator is shown in FIG. 7.
  • the treatment device shown in FIGs. 1-6 has two cooling units, each disposed on opposing sides of the vacuum cup, which each have a thermal conductor exposed to the interior cavity 216 that contacts the patient's skin.
  • the treatment device 125 having an expandable applicator shown in FIG. 7 includes two separate cooling units disposed on each side of the vacuum cup 210. In the side view of FIG. 7 only two of the cooling units, cooling units 225a and 228a are visible. The opposing side of the vacuum cup 210 may be similarly provisioned with two cooling units.
  • an expansion joint 410 may be situated between the cooling units 225a and 228a.
  • the expansion joint 410 allows the dimensions of the vacuum cup's mouth to be adjusted by the practitioner between ends 402 and 404. That is, the dimensions and configuration of the contoured distal surface 218 which contacts the epidermis can be adjusted with respect to the arc of the curved (convex) clinical surface to which treatment is to be applied. Of course, this also allows the distance between adjacent cooling units 225a and 228a to be adjusted. However, as described below, in some embodiments the expansion joint 410 is tapered so that the cooling units 225a and 228a maintain proximity at their proximal end in the vicinity of the applicator support 130 while still allowing the distance between cooling units 225a and 228a to be adjusted by the practitioner. As a result there will not be a relatively large intervening segment of adipose tissue that does not receive treatment, which clinically reduces fat cell number and fat roll size in that region.
  • the expansion joint 410 may be formed from an expandable material that connects one portion of the vacuum cup 210 to its adjacent portion.
  • FIG. 7 shows expansion joint 410 coupling adjacent portions 215 and 217 of the vacuum cup 210.
  • the expansion joint 410 may be integrally formed with the vacuum cup 210 and it may or may not be formed from the same material as the vacuum cup 210. If the expansion joint 410 is formed from the same material as the vacuum cup 210, the expansion joint 410 may be provided with a corrugated or bellows-like configuration (as indicated in FIG. 7) in order to allow it to expand and contract.
  • any suitable material may be selected which is expandable or elastic, yet firm enough to maintain its adherence to the epidermis of the patient so that the vacuum cup 210 does not collapse when a vacuum is applied to its interior cavity 216.
  • any suitable means may be used to connect them, including adhesive, fasteners and the like.
  • the expansion joint 410 begins at the mouth of the vacuum cup 210 and is tapered inward as it extends from the distal end of the vacuum cup 210 toward the proximal end.
  • the expansion joint 410 may or may not fully extend to the proximal end of the vacuum cup 210.
  • a similar expansion joint (not shown) may be located on the opposing side of the vacuum cup 210, which is not visible in FIG. 7.
  • the cooling units 225a and 228a shown in FIG. 7 are square in shape, more generally the cooling units 225a and 228a may be provided with various shapes and sizes and are not limited to the shape and size shown in FIG. 7.
  • the cooling units 225a and 228a may or may not have a curved contour on their distal surfaces such as described above in connection with FIGs. 1-5.
  • the cooling units 225a and 228b may or may not have the same size and shape with respect to one another.
  • the expansion joint 410 in FIG. 7 is located between cooling units, in some embodiments one or more expansion joints may be located on either side of the cooling units 225a and 228b, near the end 402 of the vacuum cup 410 and/or near the end 404 of the vacuum cup.
  • FIG. 8 shows another embodiment of the treatment device 125 having an expandable applicator.
  • outer expansion joints 420 and 430 are located on the side surfaces 450 and 460, respectively, which interconnect the sidewalls of the vacuum cup 210 in which the cooling units are located.
  • the outer expansion joints 420 and 430 can be used by the practitioner to adjust the distance or gap between the cooling units 220a and 220b.
  • outer expansion joints 420 and 430 may be formed from a variety of different expandable or elastic materials and they may be integrally formed with the vacuum cup or, alternatively, attached to adjacent portions of the vacuum cup 210 using any suitable technique and material, such as those discussed above.
  • an embodiment according to the present disclosure may include preparing a target area for treatment by applying a sleeve or liner for preventing direct contact between the applicator and a patient's skin, thereby reducing the likelihood of cross- contamination between patients and minimizing cleaning requirements for the applicator.
  • a thermal coupling fluid such as a cryoprotectant gel may be included with the sleeve or liner.
  • the treatment device is applied over the sleeve or liner and treatment may be initiated using the control panel described above.
  • a vacuum may be applied to pull skin and underlying adipose tissue in the target area away from the body.
  • the processor can cause the treatment device to cycle through one or more segments of a prescribed treatment plan.
  • the treatment device applies power to one or more cooling segments, such as TEEs, to begin a cooling cycle and, for example, activate features or modes such as vibration, massage, vacuum, etc.
  • the processor determines whether a temperature is sufficiently close to the target temperature has been reached. If the target temperature has not been reached, power can be increased or decreased to change the heat flux, as needed, to maintain the target temperature.
  • the processing unit may apply the temperature and duration indicated in the next treatment profile segment. Additional segments of the plan, if any, are executed by the processor until the treatment protocol is complete.
  • the applicator have a size and shape fitted to individual lipid-rich cell deposits to achieve an approximately air-tight seal.
  • a vacuum pressure is made available to draw tissue into an interior cavity for treatment, while using little or no force to maintain contact between the applicator and patient.
  • This has the effect of allowing target rolls of skin and fatty tissue to be more effectively drawn between the cooling plates, enhancing effective treatment.
  • the shape and size of the applicator and the adequacy of the suction seal are both important to the success of the cryolipolyis procedure. Achieving such a good fit may require the practitioner to maintain in stock a relatively large number of uniquely configured applicators.
  • the practitioner can select an applicator that is appropriately configured for the given patient and the particular target tissue to be treated.
  • a suitable applicator is often chosen during the treatment appointment for performing the cryolipolyis procedure. If an appropriate applicator cannot be found at this time, the procedure cannot be performed. As a result, the practitioner may lose revenue because a patient treatment time slot is wasted. Moreover, the patient may also be inconvenienced because of lost revenue from work and the lost time and expenses associated with transportation to and from the appointment. In the competitive cosmetic environment that exists today, such an outcome can adversely affect the trust between practitioner and patient.
  • cryolipolyis treatment device is relatively expensive the practitioner is likely to only have a single device available. Even in larger offices with multiple practitioners only a limited number of such devices may be available. Moreover, because of its relatively large size the device is unlikely to be portable and thus cannot be easily transported between, for example, a patient treatment room and a patient consulting room.
  • an applicator fitting arrangement or kit If the applicator fitting arrangement can be made portable or even handheld a number of different applicators can be tested on a patient during a consultative appointment.
  • the applicator fitting arrangement can be made smaller and less expensive than a fully functional cryolipolyis treatment device by eliminating unnecessary components such as the cooling unit (e.g., cooling vessel 140, fluid driver 170 and heat conduit 150) since it is relatively large and not necessary to cool the applicator in order to test its fit on the patient. Rather, all that is needed is a simple vacuum pump capable of creating a pressure differential.
  • Other components that may be eliminated from the kit may include the controller and other electronics associated with the fully functional cryolipolyis treatment device.
  • FIG. 9 One example of a handheld vacuum pump 500 that may be employed in the applicator fitting arrangement is shown in FIG. 9.
  • the vacuum pump 500 has a conduit adaptor 510 that removably engages with different applicators such as applicator 520.
  • Air pressure provided by the vacuum pump 500 can be either controlled with a regulator (not shown) located between the vacuum pump 500 and the applicator 520, or to further simplify the arrangement, pressure may be reduced up to the maximum capacity of the pump, rendering the use of a regulator unnecessary.
  • a regulator not shown
  • it is not necessary to cool the applicator it is not important to supply electrical energy to it for testing purposes, thereby further simplifying the conduit adaptor 510.
  • one of several applicators is selected by the practitioner based on the size and shape of the body region to be treated.
  • the selected applicator is attached to the vacuum pump and, in the context of a consultative appointment, the practitioner tests the fit and suction of the applicator on the body region to be treated. If the fit and seal are adequate, a treatment appointment can be scheduled with a greater degree of confidence that the treatment outcome will be successful. If the fit and seal are inadequate, or if the practitioner is not certain that the selected applicator is the most suitable one available, one or more additional applicators can be tested until a suitable applicator is found or it is determined that no suitable applicator is available.
  • the applicators that are used with the applicator fitting arrangement may be fully functional applicators which are also used during cryolipolyis treatment. Illustrative examples of such applicators are shown in FIGs. 1, 2 and 7, for example. In other embodiments, however, simplified non-functional applicators may be used which do not provide cooling functionality but are only capable of supplying a vacuum to test their fit on the patient.
  • the non-functional applicator may include nothing more than the vacuum cup. As long as the non- functional applicator is capable of being applied to cutaneous layer of the patient under a vacuum, even if no other functionality is provided, the applicator's ability to supply a vacuum allows the air-tight seal and ability to draw the epidermis into the vacuum cup can be tested. Since these testing applicators are nonfunctional, they may eliminate various components associated with cooling such as the cooling plates and the like. As a result they may be less expensive to manufacture, potentially allowing the practitioner to maintain a greater number of test applicators and applicator test kits so that more than one kit is available at any time.
  • kits, products, compositions and methods include the referenced components or steps, but not excluding others.
  • Consisting essentially of when used to define products, compositions and methods shall mean excluding other components or steps of any essential significance. Thus, a composition consisting essentially of the recited components would not exclude trace contaminants and pharmaceutically acceptable carriers.
  • Consisting of shall mean excluding more than trace elements of other components or steps.
  • embodiment of the treatment device combines the embodiments of FIGs. 7 and 8 to provide an expandable applicator having four expandable joints, each disposed on a different surface of the vacuum cup. Such an embodiment allows the gap between the cooling plates and/or the curve or arc of the treatment zone on a curved clinical surface to be adjusted.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Thermal Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

L'invention concerne un kit servant à l'ajustement d'un applicateur qui est par la suite utilisé au cours d'une intervention de cryolipolyse. Le kit inclut une pluralité d'applicateurs et une pompe à vide. Chaque applicateur parmi la pluralité d'applicateurs vient en contact avec la couche cutanée sous laquelle se trouvent les cellules riches en lipides à traiter par cryolipolyse. Chacun des applicateurs présente une taille et/ou une forme différente. La pompe à vide peut être accouplée de façon amovible à chacun des applicateurs en vue d'établir un vide au sein d'une cavité intérieure des applicateurs, ce qui permet d'aspirer la couche cutanée dans la cavité intérieure lorsque les applicateurs sont en contact avec la couche cutanée.
PCT/US2013/075091 2012-12-14 2013-12-13 Prétraitement par cryolipolyse et dispositif, système, kit et procédé d'ajustement de recherche Ceased WO2014093868A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261737310P 2012-12-14 2012-12-14
US61/737,310 2012-12-14

Publications (1)

Publication Number Publication Date
WO2014093868A1 true WO2014093868A1 (fr) 2014-06-19

Family

ID=49943517

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/075091 Ceased WO2014093868A1 (fr) 2012-12-14 2013-12-13 Prétraitement par cryolipolyse et dispositif, système, kit et procédé d'ajustement de recherche

Country Status (1)

Country Link
WO (1) WO2014093868A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069677A1 (fr) * 2015-03-17 2016-09-21 Cryotech Nordic Oü Ensemble pièce à main pour appareil utilisé dans le traitement cosmétique
WO2017168101A1 (fr) * 2016-03-31 2017-10-05 Deleo Systeme de reduction d'amas graisseux localises par le froid, applicateur pour un tel systeme et procede de traitement non invasif de reduction des graisses par le froid
CN114081713A (zh) * 2017-05-30 2022-02-25 雷森斯医疗有限公司 医疗用冷却装置及方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080287839A1 (en) * 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US20100280582A1 (en) * 2009-04-30 2010-11-04 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US20120220960A1 (en) * 2011-02-28 2012-08-30 Ruland Robert T Self-contained cryothetrapy and suction system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080287839A1 (en) * 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US20100280582A1 (en) * 2009-04-30 2010-11-04 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
US20120220960A1 (en) * 2011-02-28 2012-08-30 Ruland Robert T Self-contained cryothetrapy and suction system

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069677A1 (fr) * 2015-03-17 2016-09-21 Cryotech Nordic Oü Ensemble pièce à main pour appareil utilisé dans le traitement cosmétique
WO2017168101A1 (fr) * 2016-03-31 2017-10-05 Deleo Systeme de reduction d'amas graisseux localises par le froid, applicateur pour un tel systeme et procede de traitement non invasif de reduction des graisses par le froid
CN114081713A (zh) * 2017-05-30 2022-02-25 雷森斯医疗有限公司 医疗用冷却装置及方法
CN114081713B (zh) * 2017-05-30 2024-03-01 雷森斯医疗有限公司 医疗用冷却装置及方法
US12239571B2 (en) 2017-05-30 2025-03-04 Recensmedical, Inc. Device and method for cooling living tissue

Similar Documents

Publication Publication Date Title
US20140364841A1 (en) Cryolipolyis device having a curved applicator surface
US20250099294A1 (en) Device, system and method of removing heat from subcutaneous lipid-rich cells
AU2014203094B2 (en) Device, system and method of removing heat from subcutaneous lipid-rich cells
US20220062660A1 (en) Ultrasonic system for skin-tightening or body-shaping treatment
US10092346B2 (en) Combined modality treatment systems, methods and apparatus for body contouring applications
US10675176B1 (en) Treatment systems, devices, and methods for cooling targeted tissue
US10952891B1 (en) Treatment systems with adjustable gap applicators and methods for cooling tissue
WO2014093868A1 (fr) Prétraitement par cryolipolyse et dispositif, système, kit et procédé d'ajustement de recherche
KR101682685B1 (ko) 냉각 컵, 냉동 지방 분해 장치 및 그 제어 방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13818882

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13818882

Country of ref document: EP

Kind code of ref document: A1